Citations

Showing 10 of 108094 citations.

Clinical Outcomes and Return to Sport in Competitive Athletes Undergoing Arthroscopic Iliopsoas Fractional Lengthening Compared With a Matched Control Group Without Iliopsoas Fractional Lengthening
Perets, Itay , Hartigan, David E. , Chaharbakhshi, Edwin O., Ashberg, Lyall , Mu, Brian H. , Domb, Benjamin G.

Mayo Clinic

Arthroscopy | January 4, 2018 | Volume: 34 | Issue: 2 | Pages: 456-463

10.1016/j.arthro.2017.08.292 | PMID 29108784 Get It

Purpose To compare the minimum 2‐year outcomes and return to sports in competitive athletes after arthroscopic iliopsoas fractional lengthening (IFL) and treatment for femoroacetabular impingement (FAI) to competitive athletes treated for FAI who did not undergo IFL. Methods Data were prospectively collected and retrospectively reviewed between November 2009 and April 2014. Included patients were high school, collegiate, or professional athletes who underwent arthroscopic IFL, treatment for FAI, and preoperative modified Harris Hip Score, Non‐Arthritic Athletic Hip Score, Hip Outcome Score–Sports Specific Subscale, and visual analog scale. Exclusion criteria were patients younger than 16 years, Tönnis grade >1, microfracture, abductor pathology, and previous hip conditions. A subgroup of athletes were matched to athletes who did not undergo IFL by age ± 5 years, sex, and body mass index ± 5. Results There were 75 athletes eligible for inclusion, 60 (80.0%) of whom had minimum 2‐year follow‐up. All patient‐reported outcome (PRO) scores demonstrated significant improvements at latest follow‐up ( P < .001). Mean satisfaction was 7.9. No patients converted to arthroplasty. Painful snapping was resolved in 55 athletes (91.7%). Nine athletes (15.0%) had nonpainful snapping at follow‐up. Thirty‐nine (65%) returned to their sport. Forty (66.7%) maintained or improved their competitive abilities. There was one case (1.6%) of temporary postoperative numbness. There were no complaints of weakness in hip flexion. Forty‐one IFL athletes were matched to 41 controls. No differences were detected in demographics, follow‐up time, intraoperative findings, procedures, mean magnitudes of improvement, or return to sports. Conclusions In competitive athletes, IFL during hip arthroscopy is safe and demonstrates favorable improvements in PROs and VAS, high satisfaction, and high rate of symptom resolution at a minimum of 2 years postoperatively. Most patients were able to return to sports and maintain or improve their competitive levels. These results were similar to a control group of athletes not requiring IFL. Level of Evidence Level III, case‐control study.
Clinical Evaluation of the Vestibular Nerve Using Vestibular Evoked Myogenic Potentials
Bogle, Jamie M.

Mayo Clinic

Journal of Clinical Neurophysiology | January 4, 2018 | Volume: 35 | Issue: 1 | Pages: 39-47

10.1097/wnp.0000000000000422 | PMID 29298211 Get It

Summary: Vestibular evoked myogenic potentials are currently the most clinically accessible method to evaluate the otolith reflex pathways. These responses provide unique information regarding the status of the utriculo-ocular and sacculo-collic reflex pathways, information that has previously been unavailable. Vestibular evoked myogenic potentials are recorded from tonically contracted target muscles known to be innervated by these respective otolith organs. Diagnosticians can use vestibular evoked myogenic potentials to better evaluate the overall integrity of the inner ear and neural pathways; however, there are specific considerations for each otolith reflex protocol. In addition, specific patient populations may require protocol variations to better evaluate atypical function of the inner ear organs, vestibular nerve transmission, or subsequent reflex pathways. This is a review of the clinical application and interpretation of cervical and ocular vestibular evoked myogenic potentials.
Contemporary Risk Factors and Outcomes of Transfusion-Associated Circulatory Overload*
Roubinian, Nareg H. , Triulzi, Darrell J., Gottschall, Jerome L. , Michalkiewicz, M, Chowdhury, Dhuly , Kor, Daryl J. , Looney, Mark R. , Matthay, Michael A. , Kleinman, Steven , Brambilla, Donald , Murphy, Edward L. , Hendrickson, Jeanne E.

Mayo Clinic

Critical Care Medicine | January 4, 2018 | Volume: 46 | Issue: 4 | Pages: 577-585

10.1097/ccm.0000000000002948 | PMID 29300236 Get It

Objectives: Transfusion-associated circulatory overload is characterized by hydrostatic pulmonary edema following blood transfusion. Restrictive transfusion practice may affect the occurrence and severity of transfusion-associated circulatory overload in critically ill patients. We sought to examine contemporary risk factors and outcomes for transfusion-associated circulatory overload. Design: Case-control study. Setting: Four tertiary care hospitals. Patients: We prospectively enrolled 200 patients with transfusion-associated circulatory overload identified by active surveillance and 405 controls matched by transfusion intensity. Interventions: None. Measurements and Main Results: Among 20,845 transfused patients who received 128,263 blood components from May 2015 until July 2016, transfusion-associated circulatory overload incidence was one case per 100 transfused patients. In addition to cardiovascular comorbidities, multivariable analysis identified the following independent predictors of transfusion-associated circulatory overload: acute kidney injury, emergency surgery, pretransfusion diuretic use, and plasma transfusion—the latter especially in females. Compared with matched controls, transfusion-associated circulatory overload cases were more likely to require mechanical ventilation (71% vs 49%; p < 0.001), experienced longer intensive care and hospital lengths of stay following transfusion, and had higher mortality (21% vs 11%; p = 0.02) even after adjustment for other potentially confounding variables. Conclusions: Despite restrictive transfusion practice, transfusion-associated circulatory overload remains a frequent complication of transfusion and is an independent risk factor for in-hospital morbidity and mortality. In addition to cardiovascular and renal risk factors, plasma transfusion was associated with transfusion-associated circulatory overload after controlling for other covariates. Additional research is needed to examine the benefit of reduced erythrocyte or plasma exposure in patients at high risk for transfusion-associated circulatory overload.
Genital vibration for sexual function and enhancement: best practice recommendations for choosing and safely using a vibrator
Rullo, Jordan , Lorenz, Tierney K. , Ziegelmann, Matthew , Meihofer, Laura, Herbenick, Debby , Rullo, Jordan E, Lorenz, Tierney , Ziegelmann, Matthew J, Faubion, Stephanie S.

Mayo Clinic

Sexual and Relationship Therapy | January 4, 2018 | Volume: 33 | Issue: 3 | Pages: 275-285

10.1080/14681994.2017.1419558 | PMID 33223961 Get It

Preoperative Ultrasonography Is Unreliable in Predicting Hamstring Tendon Graft Diameter for ACL Reconstruction
Momaya, Amit , Beicker, Clint, Siffri, Paul, Kissenberth, Michael J. , Backes, Jeffrey, Bailey, Lane , Rulewicz, Gabriel J., Mercuri, Jennifer M., Shealy, E. Carlisle, Tokish, John M. , Thigpen, Charles A.

Mayo Clinic

Orthopaedic Journal of Sports Medicine | January 4, 2018 | Volume: 6 | Issue: 1 | Pages: No page available

10.1177/2325967117746146 | PMID 29318179 Get It

Background: Hamstring autograft size <8 mm has been shown to be a predictor for failure after anterior cruciate ligament (ACL) reconstruction. The ability to predict graft size preoperatively is helpful in counseling patients about the possible need for graft augmentation. Purpose: To determine whether preoperative ultrasound (US) measurements of hamstring tendons can predict intraoperative graft diameter during ACL reconstruction. Study Design: Cohort study (diagnosis); Level of evidence, 2. Methods: Twenty patients undergoing unilateral isolated ACL reconstruction were prospectively enrolled in the study (10 males, 10 females; mean ± SD age, 22.8 ± 6.6 years; height, 175.1 ± 7.1 cm; weight, 81.4 ± 14.2 kg; body mass index, 26.5 ± 4.1 kg/m 2 ). Hamstrings were assessed by US, and double-looped semitendinosus-gracilis hamstring size was independently calculated with a freehand selection method on a nonmagnified US image by 2 orthopaedic surgeons. Intraoperative autograft size was determined with a standard graft-sizing tool. Intra- and interrater reliability was measured with intraclass correlation coefficients (ICCs) and standard error of the measure (SEM). A receiver operating characteristic curve was calculated to assess the ability of the US measurement to predict intraoperative measurements. Results: The mean autograft diameter by US was 8.9 ± 0.98 mm, while the mean intraoperative hamstring graft size was 8.1 ± 0.89 mm. There was excellent intrarater (ICC 2,1 = 0.95, SEM = 0.32 mm) and interrater (ICC 2,1 = 0.88, SEM = 0.55 mm) reliability for US measurements. Receiver operating characteristic analysis showed that US did not consistently quantify graft size. Graft size did not significantly correlate with height, weight, or body mass index in our sample ( P > .05). Conclusion: These results suggest that preoperative US imaging of the hamstring tendons is unreliable in predicting intraoperative graft diameter.
Functional and clinical relevance of VLA-4 (CD49d/CD29) in ibrutinib-treated chronic lymphocytic leukemia
Tissino, Erika , Benedetti, Dania , Herman, Sarah E. M. , Hacken, Elisa ten , Ahn, Inhye E. , Chaffee, Kari G. , Rossi, Francesca Maria , Bo, Michele Dal , Bulian, Pietro , Bomben, Riccardo , Bayer, Elisabeth, Härzschel, Andrea, Gutjahr, Julia , Santinelli, Enrico , Ayed, Ayed O. , Zaja, Francesco , Chiarenza, Annalisa , Pozzato, Gabriele , Chigaev, Alexandre , Sklar, Larry A. , Hartmann, Tanja Nicole , Gattei, Valter , Zucchetto, Antonella , Rabe, Kari G. , Ayed, Ayed , Chiarenza, Annalisa , Zucchetto, Antonella , Postorino, Massimiliano , Burger, Jan A. , Ferrajoli, Alessandra , Shanafelt, Tait D. , Wiestner, Adrian U. , Poeta, Giovanni Del

Mayo Clinic

Journal of Experimental Medicine | January 4, 2018 | Volume: 215 | Issue: 2 | Pages: 681-697

10.1084/jem.20171288 | PMID 29301866 Get It

The Bruton’s tyrosine kinase (BTK) inhibitor ibrutinib, which antagonizes B cell receptor (BCR) signals, demonstrates remarkable clinical activity in chronic lymphocytic leukemia (CLL). The lymphocytosis experienced by most patients under ibrutinib has previously been attributed to inhibition of BTK-dependent integrin and chemokine cues operating to retain the tumor cells in nodal compartments. Here, we show that the VLA-4 integrin, as expressed by CD49d-positive CLL, can be inside-out activated upon BCR triggering, thus reinforcing the adhesive capacities of CLL cells. In vitro and in vivo ibrutinib treatment, although reducing the constitutive VLA-4 activation and cell adhesion, can be overcome by exogenous BCR triggering in a BTK-independent manner involving PI3K. Clinically, in three independent ibrutinib-treated CLL cohorts, CD49d expression identifies cases with reduced lymphocytosis and inferior nodal response and behaves as independent predictor of shorter progression-free survival, suggesting the retention of CD49d-expressing CLL cells in tissue sites via activated VLA-4. Evaluation of CD49d expression should be incorporated in the characterization of CLL undergoing therapy with BCR inhibitors.
Optimal Blood Pressure After Intracerebral Hemorrhage
Rabinstein, Alejandro A.

Mayo Clinic

Stroke | January 4, 2018 | Volume: 49 | Issue: 2 | Pages: 275-276

10.1161/strokeaha.117.020058 | PMID 29301975 Get It

Intravenous delivery of oncolytic reovirus to brain tumor patients immunologically primes for subsequent checkpoint blockade
Samson, Adel , Scott, Karen J. , Taggart, David J. , Wilson, Erica , Nuovo, Gerard J. , Thomson, Simon , Mathew, Ryan , Fuller, Martin, Kottke, Timothy, Thompson, Jill , Ilett, Elizabeth J. , Cockle, Julia , Hille, Philip van, Sivakumar, Gnanamurthy, Polson, Euan S. , Turnbull, Samantha , Appleton, Elizabeth , Migneco, G , Rose, Ailsa , Coffey, Matthew, Beirne, Deborah , Collinson, Fiona , Ralph, Christy , Anthoney, Alan , Twelves, Christopher , Furness, Andrew J.S. , Quezada, Sergio A. , Wurdak, Heiko , Errington‐Mais, Fiona , Pandha, Hardev , Harrington, Kevin J. , Selby, Peter J. , Vile, Richard G. , Griffin, Stephen , Stead, Lucy F. , Short, Susan , Melcher, Alan , Taggart, David , Wilson, Erica , Nuovo, Gerard J , Thomson, Simon , Mathew, Ryan K , Kottke, Timothy J, Thompson, Jill M, Ilett, Elizabeth J , Cockle, Julia V , Turnbull, Samantha J , Rose, Ailsa S , Beirne, Deborah A , Ralph, Christy , Alan Anthoney, D , Quezada, Sergio A , Wurdak, Heiko , Errington-Mais, Fiona , Selby, Peter J , Griffin, Stephen , Stead, Lucy F , Short, Susan C , Melcher, Alan A , Harrington, Kevin , West, Emma J. , Corns, Robert A. , Appleton, Elizabeth

Mayo Clinic

Science Translational Medicine | January 3, 2018 | Volume: 10 | Issue: 422 | Pages: No page available

10.1126/scitranslmed.aam7577 | PMID 29298869 Get It

Intravenous infusion of oncolytic reovirus in patients leads to infection of brain tumors, infiltration by cytotoxic T cells, and up-regulation of PD-L1.
Impact of sleep deprivation on the outcomes of percutaneous coronary intervention
Iverson, Ann , Stanberry, Larissa , Garberich, Ross , Antos, Amber, Sandoval, Yader , Burke, M. Nicholas , Chavez, Ivan , Gössl, Mario , Henry, Timothy D. , Lips, Daniel, Poulose, Anil, Sorajja, Paul , Wang, Yale , Sorajja, Paul , Brilakis, Emmanouil S , Nicholas Burke, M , Mooney, Michael R , Traverse, Jay H. , Bradley, Steven M. , Brilakis, Emmanouil S.

Mayo Clinic

Catheterization and Cardiovascular Interventions | January 3, 2018 | Volume: 92 | Issue: 6 | Pages: 1118-1125

10.1002/ccd.27471 | PMID 29314592 Get It

AbstractObjectivesThis study sought to compare the clinical outcomes of percutaneous coronary interventions (PCIs) performed by sleep deprived and non‐sleep deprived operators.BackgroundInterventional cardiologists are at risk for sleep deprivation as they often have to perform emergent procedures at night, but the effects of sleep deprivation on clinical outcomes have received limited study.MethodsWe examined the frequency, clinical characteristics, and outcomes of daytime PCIs performed by sleep deprived and non‐sleep deprived operators at a tertiary medical center. Operators were considered sleep deprived when performing a daytime (7 am–11:59 pm) procedure preceded by a nighttime (12 am–6:59 am) procedure on the same date.ResultsOf the 12,680 daytime PCIs performed from 6/29/09 to 12/30/2016, 367 (2.9%) were performed by sleep deprived operators. Patients undergoing PCI performed by a sleep deprived operator were more likely to be younger, white, and to present with ST‐elevation acute myocardial infarction (STEMI). The incidence of in‐hospital death (1.1% vs. 1.3%, P = 1.0) and bleeding within 72 hr (3.9% vs. 2.9%, P = 0.29) were similar for procedures performed by sleep‐deprived and non‐sleep deprived operators. When the sleep deprived group was further stratified based on degree of sleep deprivation or length of sleep interruption, differences in mortality and total bleeding remained non‐significant.ConclusionsIn this large single center study, operator sleep deprivation did not appear to adversely impact PCI outcomes.
A Clinical Trial Protocol Paper Discussing the Brighter Study
Sonbol, Mohamad Bassam , Bekaii‐Saab, Tanios , Sonbol, Mohamad B , Bekaii-Saab, Tanios S

Mayo Clinic

Future Oncology | January 3, 2018 | Volume: 14 | Issue: 10 | Pages: 901-906

10.2217/fon-2017-0406 | PMID 29297698 Get It